Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?

Ince, Semra; Laforest, Richard; Itani, Malak; Prasad, Vikas; Derenoncourt, Paul-Robert; Crandall, John P; Ashrafinia, Saeed; Smith, Anne M et al. · J Nucl Med · 2024

Where this comes from

Abstract

In oncologic PET, the SUV and standardized uptake ratio (SUR) of a viable tumor generally increase during the postinjection period. In contrast, the net influx rate (<i>K<sub>i</sub></i> ), which is derived from dynamic PET data, should remain relatively constant. Uptake-time-corrected SUV (cSUV) and SUR (cSUR) have been proposed as uptake-time-independent, static alternatives to <i>K<sub>i</sub></i> Our primary aim was to quantify the intrascan repeatability of <i>K<sub>i</sub></i> , SUV, cSUV, SUR, and cSUR among malignant lesions on PET/CT. An exploratory aim was to assess the ability of cSUR to estimate <i>K<sub>i</sub></i> <b>Methods:</b> This prospective, single-center study enrolled adults undergoing standard-of-care oncologic PET/CT. SUV and <i>K<sub>i</sub></i> images were reconstructed from dynamic PET data obtained before (∼35-50 min after injection) and after (∼75-90 min after injection) standard-of-care imaging. Tumors were manually segmented. Quantitative metrics were extracted. cSUVs and cSURs were calculated for a 60-min postinjection reference uptake time. The magnitude of the intrascan test-retest percent change (test-retest |%Δ|) was calculated. Coefficients of determination (<i>R</i> <sup>2</sup>) and intraclass correlation coefficients (ICC) were also computed. Differences between metrics were assessed via the Wilcoxon signed-rank test (α, 0.05). <b>Results:</b> This study enrolled 78 subjects; 41 subjects (mean age, 63.8 y; 24 men) with 116 lesions were analyzed. For both tracers, SUV<sub>max</sub> and maximum SUR (SUR<sub>max</sub>) had large early-to-late increases (i.e., poor intrascan repeatability). Among [<sup>18</sup>F]FDG-avid lesions (<i>n</i> = 93), there were no differences in intrascan repeatability (median test-retest |%Δ|; ICC) between the maximum <i>K<sub>i</sub></i> (<i>K<sub>i</sub></i> <sub>,max</sub>) (13%; 0.97) and either the maximum cSUV (cSUV<sub>max</sub>) (12%, <i>P</i> = 0.90; 0.96) or the maximum cSUR (cSUR<sub>max</sub>) (13%, <i>P</i> = 0.67; 0.94). For DOTATATE-avid lesions (<i>n</i> = 23), there were no differences in intrascan repeatability between the <i>K<sub>i</sub></i> <sub>,max</sub> (11%; 0.98) and either the cSUV<sub>max</sub> (13%, <i>P</i> = 0.41; 0.98) or the cSUR<sub>max</sub> (11%, <i>P</i> = 0.08; 0.94). The SUV<sub>max</sub>, cSUV<sub>max</sub>, SUR<sub>max</sub>, and cSUR<sub>max</sub> were all strongly correlated with the <i>K<sub>i</sub></i> <sub>,max</sub> for both [<sup>18</sup>F]FDG (<i>R</i> <sup>2</sup>, 0.81-0.92) and DOTATATE (<i>R</i> <sup>2</sup>, 0.88-0.96), but the cSUR<sub>max</sub> provided the best agreement with the <i>K<sub>i</sub></i> <sub>,max</sub> across early-to-late time points for [<sup>18</sup>F]FDG (ICC, 0.69-0.75) and DOTATATE (ICC, 0.90-0.91). <b>Conclusion:</b> <i>K<sub>i</sub></i> <sub>,max</sub>, cSUV<sub>max</sub>, and cSUR<sub>max</sub> had low uptake time dependence compared with SUV<sub>max</sub> and SUR<sub>max</sub> The <i>K<sub>i</sub></i> <sub>,max</sub> can be predicted from cSUR<sub>max</sub>.

Medical subject headings